| ²é¿´: 238 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ncpcmsdľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¶Ò©Æ·ÕٻعÜÀí°ì·¨¡·£¨¾ÖÁîµÚ29ºÅ£©
|
||
|
¡¶Ò©Æ·ÕٻعÜÀí°ì·¨¡·ÓÚ2007Äê12ÔÂ6ÈÕ¾¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö¾ÖÎñ»áÉóÒéͨ¹ý£¬ÏÖÓ蹫²¼£¬×Ô¹«²¼Ö®ÈÕÆðÊ©ÐС£ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¾Ö³¤£ºÉÛÃ÷Á¢ ¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¶þ¡ð¡ðÆßÄêÊ®¶þÔÂÊ®ÈÕ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ4È˻ظ´
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ccyyhh
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3540.3
- É¢½ð: 1427
- ºì»¨: 1
- Ìû×Ó: 406
- ÔÚÏß: 85.9Сʱ
- ³æºÅ: 474666
- ×¢²á: 2007-12-06
- ÐÔ±ð: MM
- רҵ: ҩѧ
3Â¥2007-12-29 08:41:50
ccyyhh
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3540.3
- É¢½ð: 1427
- ºì»¨: 1
- Ìû×Ó: 406
- ÔÚÏß: 85.9Сʱ
- ³æºÅ: 474666
- ×¢²á: 2007-12-06
- ÐÔ±ð: MM
- רҵ: ҩѧ
2007ÄêÊ®´ó±»¾¯¸æ/ÕÙ»ØÒ©Îï
|
2007ÄêÊ®´ó±»¾¯¸æ/ÕÙ»ØÒ©Îï 2007ÄêÊÇÒ»¸öÒ©Îﰲȫ¾¯¸æ¸ß·¢Äê¡£FiercePharma¹«Ë¾¸ù¾Ý½ñÄêÒÔÀ´ÃÀ¹úFDA·¢²¼µÄÒ©Îᆵ¸æ»ò³·ÏúµÄ¹«¸æ£¬ÁгöÁË10´ó¾¯¸æºÍÕлØÒ©ÎïÃûµ¥£¨¸ù¾Ý2006ÄêÒ©ÎïÈ«ÇòÏúÁ¿ÅÅÁУ©¡£ µÚÒ»ÊÇ¿¹ÒÖÓôÒ©£¬2006ÄêÏúÁ¿ÊÇ206ÒÚÃÀÔª£»FDAÏò36ÖÖ¿¹ÒÖÓôÒ©µÄÖÆÔìÉÌÌáÒ飬¸üÐÂÒÑÓеĺڿò¾¯¸æÄÚÈÝ£¬±ê×¢£ºÔÚ18¡«24ËêµÄÄêÇáÈËÖУ¬Ò©Îï¾ßÓÐÔö¼Ó×ÔɱµÄ˼ÏëºÍÐÐΪµÄΣÏÕ£¬¼´×ÔɱÐÔÇãÏò£¬Í¨³£ÔÚÍ·1¡«2¸öÔ¡£ µÚ¶þÊÇÖØ×éÈË´Ùºìϸ°ûÉú³ÉËØEpogenºÍAranesp£¬2006ÄêÏúÁ¿ÊÇ41ÒÚÃÀÔªºÍ25ÒÚÃÀÔª£»FDA¸øÆäºÚ¿ò¾¯¸æ£¬±ê×¢£º¸ß¼ÁÁ¿ÒýÆðÐÄÔàºÍѪ¹ÜÎÊÌâ¡£ µÚÈýÊÇÓÃÓÚÖÎÁƾ«Éñ·ÖÁÑÖ¢µÄ°ÂµªÆ½£¨olanzapine£¬ÔÙÆÕÀÖ£¬Zyprexa£©£¬2006ÄêÏúÁ¿ÊÇ44ÒÚÃÀÔª£»±ê×¢£º½«²úÉúÌåÖØÔö¼Ó¼°´úлÎÊÌâ¡£ µÚËÄÊÇ¿¹ÌÇÄò²¡Ò©ÂíÀ´ËáÂÞ¸ñÁÐͪ£¨rosiglitazone maleate£¬ÎĵÏÑÅ£¬Avandia£©£¬2006ÄêÏúÁ¿ÊÇ34ÒÚÃÀÔª£»ºÚ¿ò¾¯¸æ£º¿ÉÄÜÒýÆðÐÄÁ¦Ë¥½ß¡¢Ð£Èû¡£ µÚÎåÊÇ¿¹ÌÇÄò²¡Ò©ßÁ¸ñÁÐͪ£¨pioglitazone£¬Actos£©£¬2006ÄêÏúÁ¿Îª30.5ÒÚÃÀÔª£»ºÚ¿ò¾¯¸æ£º¿ÉÄÜÒý·¢ÐÄÁ¦Ë¥½ß¡£ µÚÁùÊÇÌáÉñÒ©modafinil£¨Äª´ï·ÇÄᣬProvigil£©£¬2006ÄêÏúÁ¿ÊÇ7.27ÒÚÃÀÔª£»¾¯¸æ£º¿ÉÄÜÒý·¢Éø³öÐÔ¶àÐÎ(ÐÔ)ºì°ß£¨Stevens-Johnson syndrome£©¡¢¾«Éñ²¡ÎÊÌâ¡£ µÚÆßÊÇÖÎÁÆÅ®ÐÔ±ãÃØµÄÌæ¼ÓÉ«ÂÞ£¨tegaserod£¬ÔóÂí¿É£¬Zelnorm£©£¬2006ÄêÏúÁ¿ÊÇ5.61ÒÚÃÀÔª£»ÏÖÒѱ»Õٻأ¬ÒòΪ´æÔÚÒý·¢ÐÄÔಡµÄΣÏÕ¡£ µÚ°ËÊÇ2ÐÍÌÇÄò²¡³¤Ð§×¢Éä¼Á°¬ÈûÄÇëÄ£¨exenatide£¬Byetta£©£¬2006ÄêÏúÁ¿ÊÇ4.3ÒÚÃÀÔª£»¾¯¸æ£º¿ÉÄÜÒý·¢ÒÈÏÙÑס£ µÚ¾ÅÊÇÖÎÁÆÏø´µÄomalizumab£¨Xolair£©£¬2006ÄêÏúÁ¿Îª4.25ÒÚÃÀÔª£»ºÚ¿ò¾¯¸æ£º¹ýÃôÐÔ¼²²¡¡£ µÚÊ®ÊÇֹʹҩ·ÒÌ«Äá¿ÚǻƬ£¨Fentora£©£¬2006ÄêÏúÁ¿ÊÇ3.7ÒÚÃÀÔª£»¾¯¸æ£º²»ºÏÊʵļÁÁ¿¿ÉÄܵ¼ÖÂËÀÍö¡£ |
2Â¥2007-12-29 08:30:20














»Ø¸´´ËÂ¥